ACTG Publications

TitleAuthorsDateJournalIssueVolume
Variations in self-rated health among patients with HIV infection.Mrus, Joseph M ; Schackman, Bruce R ; Wu, Albert W ; Freedberg, Kenneth A ; Tsevat, Joel ; Yi, Michael S ; Zackin, Robert2006 AprQual Life Res315
Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211.Yeh, Tzu-min ; Evans, Scott R ; Gulick, Roy M ; Clifford, David B2010 Jan-FebHIV Clin Trials111
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.Tsibris, Athe M N ; Hu, Zixin ; Paredes, Roger ; Leopold, Kay E ; Putcharoen, Opass ; Schure, Allison L ; Mazur, Natalie ; Coakley, Eoin ; Su, Zhaohui ; Gulick, Roy M ; Kuritzkes, Daniel R2012 JunJ Virol1286
Viral factors associated with cytokine expression during HCV/HIV co-infection.Blackard, Jason T ; Kang, Minhee ; St Clair, J Benjamin ; Lin, Wenyu ; Kamegaya, Yoshitaka ; Sherman, Kenneth E ; Koziel, Margaret James ; Peters, Marion G ; Andersen, Janet ; Chung, Raymond T ; Aids Clinical Trials Group A5071 Study Team2007 AprJ Interferon Cytokine Res427
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.Cillo, Anthony R ; Hilldorfer, Benedict B ; Lalama, Christina M ; McKinnon, John E ; Coombs, Robert W ; Tenorio, Allan R ; Fox, Lawrence ; Gandhi, Rajesh T ; Ribaudo, Heather ; Currier, Judith S ; Gulick, Roy M ; Wilkin, Timothy J ; Mellors, John W2015 Oct 23AIDS1629
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.Markowitz, Martin ; Vaida, Florin ; Hare, C Bradley ; Boden, Daniel ; Mohri, Hiroshi ; Hecht, Frederick M ; Kalayjian, Robert C ; Conrad, Ann ; Mildvan, Donna ; Aberg, Judith ; Hogan, Christine ; Kilby, J Michael ; Balfour, Henry H ; Schafer, Kim ; Richman, Douglas ; Little, Susan2010 May 1J Infect Dis9201
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.Kang, Minhee ; Hollabaugh, Kimberly ; Pham, Vinh ; Koletar, Susan L ; Wu, Kunling ; Smurzynski, Marlene ; Aberg, Judith A2014 Jun 1J Acquir Immune Defic Syndr266
Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase.Hu, Zixin ; Hatano, Hiroyu ; Hammond, Sarah P ; Smith, Danielle ; Wild, Mary ; Gupta, Soumi ; Whitcomb, Jeannette ; Kalayjian, Robert C ; Gripshover, Barbara ; Kuritzkes, Daniel R2007 Aug 15J Acquir Immune Defic Syndr545
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.Mitsuyasu, Ronald ; Gelman, Rebecca ; Cherng, Deborah Weng ; Landay, Alan ; Fahey, John ; Reichman, Richard ; Erice, Alejo ; Bucy, R Pat ; Kilby, J Michael ; Lederman, Michael M ; Hamilton, Carol D ; Lertora, Juan ; White, Becky L ; Tebas, Pablo ; Duliege, Anne-Marie ; Pollard, Richard B ; AIDS Clinical Trials Group 328 Study Team2007 Mar 26Arch Intern Med6167
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.Overton, Edgar Turner ; Chan, Ellen S ; Brown, Todd T ; Tebas, Pablo ; McComsey, Grace A ; Melbourne, Kathleen M ; Napoli, Andrew ; Hardin, William Royce ; Ribaudo, Heather J ; Yin, Michael T2015 Jun 16Ann Intern Med12162
Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.Natsag, J ; Kendall, M A ; Sellmeyer, D E ; McComsey, G A ; Brown, T T2016 MarHIV Med317